• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

JUUL
FinanceAltria invested $13 billion in Juul. As the U.S. moves to ban e-cigarettes, their value has gone up in smoke
By Matthew Perrone and The Associated PressJuly 28, 2022
Birth Control Pills
HealthPharma company asks to be the first to sell its birth control over the counter
By Matthew Perrone and The Associated PressJuly 11, 2022
Paxlovid COVID-19 pill
HealthThe FDA is allowing pharmacists to prescribe COVID-19 pill Paxlovid
By Matthew Perrone, Tom Murphy and The Associated PressJuly 6, 2022
FDA bans Juul e-cigarettes
HealthFDA bans Juul e-cigarettes amid spike in teen vaping
By Matthew Perrone and The Associated PressJune 23, 2022
A nurse prepares a pediatric dose of the Pfizer-BioNTech Covid-19 vaccine.
HealthFDA restricts Johnson & Johnson’s COVID-19 vaccine to people 18 and older due to blood clot risk
By Matthew Perrone, Lauran Neergaard and The Associated PressMay 5, 2022
Man receives Pfizer COVID vaccine
HealthFDA approves additional Pfizer and Moderna COVID boosters for adults 50 and older
By Lauran Neergaard, Matthew Perrone and The Associated PressMarch 29, 2022
Moderna vaccine full FDA approval
HealthModerna COVID-19 vaccine gets full approval from the FDA
By Matthew Perrone and The Associated PressJanuary 31, 2022
Merck covid 19 pill
HealthFDA authorizes Merck COVID pill a day after approving Pfizer’s
By Matthew Perrone and The Associated PressDecember 23, 2021
Pfizer logo pill
HealthPfizer pill becomes first FDA-approved home COVID treatment
By Matthew Perrone and The Associated PressDecember 22, 2021
FDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
HealthFDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
By Lauran Neergaard, Matthew Perrone and The Associated PressNovember 19, 2021
Pfizer CEO Albert Bourla
HealthPfizer seeks emergency FDA authorization for COVID-19 pill
By Matthew Perrone and The Associated PressNovember 16, 2021
FDA authorizes COVID vaccine for kids ages 5 to 11
HealthFDA authorizes COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 29, 2021
Vaccines for kids
HealthFDA panel backs Pfizer’s COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 26, 2021
Moderna vaccine
HealthFDA approves Moderna and Johnson & Johnson boosters, as well as mixing COVID vaccines
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 20, 2021
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
HealthFDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 14, 2021
1...
  • 4
  • 5
  • 6
  • 7
  • 8
8
Most Popular
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our and Privacy Policy |  | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.